SEED Co.,Ltd.

7743.T
Medical Instruments & Supplies
2026/08/21 Updated
Market Cap: $101.3M (¥16.1B)
Stock Price: $3.35 (¥532)
Exchange Rate: 1 USD = ¥158.98

Seed Co., Ltd. Q1 Financial Summary [Japanese GAAP] (Consolidated) for fiscal year ending March 2027

For the consolidated net sales in the first quarter of FY ending March 2027: 8,848 hundred million yen (up 3.5% YoY); operating income: 618 hundred million yen; ordinary income: 517 hundred million yen; net income attributable to owners of the parent: 336 hundred million yen. Full-year projections unchanged. Included newly consolidated Ocudebiz (Okudebiz) in the scope. Maximum manufacturing capacity is assumed at about 82.5 million units per month; second-year plan revisions have been made.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • Net sales: 8,848百万円(前年同期比3.5%増)
  • Operating income: 618百万円(前年同期比△2.0%)
  • Ordinary income: 517百万円(前年同期比△14.9%)

AI要約

Overview of results

Sales were up year over year in this quarter. However, operating income, ordinary income, and net income declined versus the previous year. By segment, sales recovery and stronger demand for new products contributed domestically and internationally. Meanwhile, increases in personnel and R&D costs weighed on profits. Net income for the quarter attributable to owners of the parent was 336 hundred million yen.

Outlook and key points

There is no change to the full-year earnings guidance for the FY ending March 2027. While expecting higher sales, attention will be paid to raw material and energy costs. The inclusion of Ocudebiz as a new consolidated scope may accelerate future capital and business alliances. The final production capacity has been revised with a upper limit of 82.5 million units per month.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Seed Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →